Skip to product information
1 of 1

Shulph Ink

Mass Spectrometry-Based Metabolomics in Clinical and Herbal Medicines: Strategies, Technologies, and Applications

Mass Spectrometry-Based Metabolomics in Clinical and Herbal Medicines: Strategies, Technologies, and Applications

YOU SAVE £27.93

Regular price £99.02 GBP
Regular price £126.95 GBP Sale price £99.02 GBP
22% OFF Sold out
Tax included. Shipping calculated at checkout.
  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Dispatches within 7 to 10 working days
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about Mass Spectrometry-Based Metabolomics in Clinical and Herbal Medicines: Strategies, Technologies, and Applications


Mass spectrometry-based metabolomics is an important tool in clinical research and the diagnosis of human disease, offering new opportunities for biomarker discovery and pathological understanding. It is used to discover and identify perturbed pathways and has been applied to clinical research and the diagnosis of human disease. This book covers the current state, challenges, and applications of high-throughput mass spectrometry-based metabolomics, including metabolites analysis, biomarker discovery, natural product discovery, mechanism interpretation of action, clinical application, and precision medicine. It also highlights the value of mass spectrometry-based metabolomics and metabolism to address the complexity of herbal medicines in systems pharmacology.

Format: Hardback
Length: 288 pages
Publication date: 01 September 2021
Publisher: Wiley-VCH Verlag GmbH


Mass spectrometry-based metabolomics is a powerful tool for identifying biomarkers that can accurately screen for potential biomarkers of diseases. It is the systematic analysis of low-molecular-weight metabolites in biological samples and has been applied to discovering and identifying the perturbed pathways in complex diseases. This approach has become an important tool in clinical research and the diagnosis of human disease.

Mass spectrometry-based metabolomics offers new opportunities for biomarker discovery in complex diseases. It can provide pathological understanding of diseases beyond traditional technologies. By analyzing the low-molecular-weight metabolites in biological samples, researchers can identify the perturbed pathways that are associated with disease development. This information can help in developing new treatments and therapies for diseases.

In clinical research, mass spectrometry-based metabolomics has been used to identify biomarkers that can predict the response to treatments, diagnose diseases at an early stage, and monitor disease progression. It has also been used to identify potential drug targets and to develop personalized medicine approaches.

Mass spectrometry-based metabolomics has applications in various fields, including clinical and herbal medicines. In clinical medicine, it can be used to analyze blood, urine, and other biological samples to identify biomarkers that are associated with different diseases. It can also be used to monitor the effects of treatments and to predict disease recurrence.

In herbal medicines, mass spectrometry-based metabolomics can be used to analyze the phytochemicals in herbal extracts and to identify the active ingredients that are responsible for their therapeutic effects. It can also be used to link phytochemical analysis with the assessment of pharmacological effect and therapeutic potential.

Mass spectrometry-based metabolomics is a rapidly evolving field with many challenges. One of the challenges is the high cost of equipment and the need for specialized expertise. Another challenge is the large amount of data that is generated, which requires efficient data analysis and interpretation.

Despite these challenges, mass spectrometry-based metabolomics is a promising tool for identifying biomarkers that can accurately screen for potential biomarkers of diseases. It has the potential to revolutionize the way we diagnose and treat diseases and to improve our understanding of the underlying mechanisms of disease development.

In conclusion, mass spectrometry-based metabolomics is a powerful tool for identifying biomarkers that can accurately screen for potential biomarkers of diseases. It offers new opportunities for biomarker discovery in complex diseases and can provide pathological understanding of diseases beyond traditional technologies. Mass spectrometry-based metabolomics has applications in clinical research and herbal medicines and is a rapidly evolving field with many challenges. However, with continued research and development, it has the potential to revolutionize the way we diagnose and treat diseases.

Weight: 694g
Dimension: 249 x 176 x 19 (mm)
ISBN-13: 9783527349913

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Canada, France, Ireland, Italy, Germany, Spain, Netherlands, New Zealand, United States of America, Belgium, India, United Arab Emirates.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for international orders.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details